Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

145 results about "Specific identification" patented technology

Specific identification is a method of finding out ending inventory cost. It requires a detailed physical count, so that the company knows exactly how many of each goods brought on specific dates remained at year end inventory.

Matrix metalloproteinase-2 specific multi-modality molecular image probe and preparation method and application in preparation of tumor imaging agent thereof

The invention discloses a matrix metalloproteinase-2 specific multi-modality molecular image probe preparation method and application thereof. The preparation method comprises the following steps: 1)preparing peptide substrates for matrix metalloproteinase-2(MMP-2) specific identification; 2) modifying near infrared fluorescent dye on peptide substrate; 3) modifying fluorescent quenching group onpeptide substrate; 4) connecting different molecular weight PEG or tumor targeting group RGD on peptide substrate modified with near infrared fluorescent dye and fluorescent quenching group; 5) labeling the nuclide on the above modified peptide substrate side chain tyrosine. Compared with the prior art, the matrix metalloproteinase-2 specific multi-modality molecular image probe preparation method has the advantages that: 1) by utilizing the specificity and responsiveness of the MMP-2 protease by the probe, so that the probe is selectively enriched at the tumor site so as to improve the targeting property of the probe to the tumor; 2) performing multi-modality imaging in a living body tumor by using advanced molecular imaging technology such as optical, opto-acoustic, SPECT and the like,improving the sensitivity and accuracy of tumor imaging, and finally achieving accurate positioning of the tumor; 3) providing a new train of thought and method for early diagnosis, process research and prognosis evaluation of tumor.
Owner:苏州智影特生物医药技术有限公司

QCM detection method for detecting lysozyme based on multiple signal amplification technologies and application

The invention discloses a QCM detection method for detecting lysozyme based on multiple signal amplification technologies and application. The QCM detection method comprises the following steps that DNA hybridizes with lysozyme aptamer partially in a complementary mode, and through the specific binding reaction of the lysozyme and the lysozyme aptamer, the DNA is released; a Y-shaped structure is formed by complementary hybrid of the released DNA with hairpin DNA and assistant DNA modified on a gold leaf, and under the action of restriction enzyme, the hairpin DNA is cut and opened through specific identification sites; under the action of DNA ligase and DNA polymerase, using locking-ring-shaped DNA as a template chain, polymerization growing along the opened hairpin DNA is carried out, and a single chain with a large number of repeated sequences is formed; a signal probe marked with biotin hybridizes with the generated repeated sequences in a complementary mode, and after binding with streptavidin marked by HRP, hydrogen peroxide is catalyzed to oxidize 4-chloro naphthol, and precipitation reaction is generated; and accordingly the chip surface quality is increased, and the high-sensitivity detection of the QCM to the lysozyme is realized.
Owner:QINGDAO UNIV

Novel high-sensitivity LM (listeria monocytogene) detection method based on aptamer modified porous alumina membrane

The invention relates to a fast ultra-sensitive LM (listeria monocytogene) detector based on nanochannel confinement characteristics and constructed according to the nature of specific identification between a target molecule and an aptamer of the target molecules. The invention further relates to a method for detecting the LM by taking potassium ferricyanide ions as probe ions and taking an LM DNA modified porous alumina membrane as an electrode for assembling a self-made electrolytic tank. When LM is present and the concentration is lower, a current increasing value is remarkably reduced with the increase of the concentration; a current change value is reduced with increase of the LM concentration; when the LM concentration is in a range of 100-1,250 CFU/mL, a linear relation is formed between the LM concentration and the current increasing value; when the LM concentration is higher than 1,500 CFU/mL, the current change value becomes stable. Therefore, the lowest detection limit of the detection method for the LM can reach 100 CFU/mL, the linear range is 100-1,250 CFU/mL, and the detection can be completed within 10 min; a 108 CFU/mL of escherichia coli and staphylococcus aureus control experiment indicates that the method has high selectivity on the LM.
Owner:GUANGDONG OCEAN UNIVERSITY

Molecularly imprinted photonic crystal film for rapidly detecting lysozyme, and preparation method and application thereof

The invention relates to a molecularly imprinted photonic crystal film for rapidly detecting lysozyme and belongs to the field of material chemistry and analysis and detection. The molecularly imprinted photonic crystal film is characterized in that the molecularly imprinted photonic crystal film which can realize specific identification and binding to lysozyme protein molecules and has the inverse opal structure is prepared by combining silica photonic crystal microspheres with the molecular imprinting technology. As the number of the bound lysozyme protein molecules increases, the macroporous structure on the film changes, the Bragg diffraction wavelength of the prepared molecularly imprinted photonic crystal film is made to realize red shift. According to the spectral response of the prepared molecularly imprinted photonic crystal gel membrane to the lysozyme, rapid detection of the concentration of the lysozyme in the sample can be realized. The molecularly imprinted photonic crystal film is advantaged in that properties of high sensitivity and selectivity and low detection limit are realized, and the molecularly imprinted photonic crystal film can be used as a biosensor used for rapidly detecting the lysozyme protein molecules in a biological sample.
Owner:SHANGHAI E K M BIOTECH

GS (glutamine synthetase) gene specific identification crRNA and application thereof

ActiveCN105950622AMixed knockouts are easily achievedImprove efficiencyNucleic acid vectorFermentationProtein targetWild type
The invention belongs to the field of cell and gene engineering, genetic modification and therapeutic recombinant protein industrial production, and particularly relates to GS (glutamine synthetase) gene specific identification crRNA and application thereof. DNA (deoxyribonucleic acid) sequences identified by the GS gene specific identification crRNA are selectively DNA sequences shown as one of sequences SEQ ID NO.1-SEQ ID NO.8. The GS gene specific identification crRNA and the application have the advantages that GS genes of diversified cells can be specifically identified by the GS gene specific identification crRNA, the GS gene specific identification crRNA is wide in applicability, and integral procedures can be implemented easily and efficiently; the target protein expression quantities of cells without the GS genes can be greatly increased on the basis of imported exogenous carriers as compared with wild host cells, and accordingly required-to-be-inputted labor, material resources and financial resources for screening protein expression cell strains can be reduced; the GS genes are knocked out, and accordingly the industrial production cost can be reduced; the cells without the GS are used as host target gene expression cells, other chemical substances can be omitted in procedures for producing the cells, and accordingly the production safety can be improved.
Owner:苏州晟济药业有限公司

Water-soluble cationic polyelectrolyte with end group provided with fluorophore pyrene, and preparation method and application thereof

The invention relates to a fluorescent high-molecular polymer and a preparation method of the fluorescent high-molecular polymer, in particular relates to a water-soluble cationic polyelectrolyte with an end group provided with fluorophore pyrene, a preparation method of the water-soluble cationic polyelectrolyte, and an application of water-soluble cationic polyelectrolyte in the detection of base sequences of nucleic acid molecules. A novel multi-stranded fluorescent probe is formed by electrostatic adsorption and hydrophobic interaction between the water-soluble cationic polyelectrolyte with the end group provided with fluorophore pyrene and single-stranded oligomerization nucleic acid molecules (DNAs with a hairpin structure and a linear chain structure). When nucleic acid molecules with base sequence structures complementary with those of the fluorescent probe exist, hybridization is performed through Watson-Crick base pairing principle, as the fluorescent pyrene at the end group is inserted into a DNA double-helix structure, the quenching ability of the base to the pyrene fluorescence is enhanced, so that the fluorescence intensity of the pyrene is remarkably reduced compared with that of the pyrene acted on non-target nucleic acid molecules, therefore, the specific identification of the base sequence structures of the nucleic acid molecules can be realized through difference of fluorescence properties of polyelectrolyte with fluorophore pyrene.
Owner:UNIV OF SCI & TECH BEIJING

Mouse anti-human CD61 monoclonal antibody hybridoma cell line, monoclonal antibody and preparation method and application thereof and flow cytometry detection reagent

The invention discloses a mouse anti-human CD61 monoclonal antibody hybridoma cell line, a monoclonal antibody and a preparation method and application thereof and a flow cytometry detection reagent, and belongs to the technical field of biological engineering. According to the mouse anti-human CD61 monoclonal antibody hybridoma cell line, human peripheral blood leukocytes are used as an immunogen for immunizing Balb / c mice; a cell fusion technology is adopted and hybridoma cells are screened by utilizing an immunocytochemistry and a flow cytometry indirect immunofluorescent method; an antibody generated by monoclonal hybridoma cells is subjected to specific identification by applying an immunoprecipitation-mass-spectrometric method; Western Blot proves that one hybridoma cell line IID5G8 capable of stably secreting a mouse anti-human CD61 monoclonal antibody is obtained and a preservation number is CGMCC (China General Microbiological Culture Collection Center) No. 13300. The monoclonal antibody is prepared by adopting an animal in-vivo induction method; a heavy chain of the antibody is identified to be IgG1 and a light chain is identified to be kappa type; after the antibody is purified, an FITC (Fluorescein Isothiocyanate) label can be used for detecting antigen expression of human peripheral blood platelets CD61 by utilizing flow cytometry direct-labeling immunofluorescence.
Owner:HENAN UNIV OF CHINESE MEDICINE

Herbicide-resistant corn HH2823 transformation event capable of efficiently utilizing nutrients and specific identification method and application of herbicide-resistant corn HH2823 transformation event

The invention belongs to the technical field of biology, and relates to a herbicide-resistant corn HH2823 corn transformation event for efficiently utilizing nutrients of AlHAK1 and bar genes and a specific identification method and application of the herbicide-resistant corn HH2823 corn transformation event. The transformation event takes a nucleotide sequence shown in SEQ ID NO.1 as a left wingsequence of an exogenous gene and takes a nucleotide sequence shown in SEQ ID NO.2 as a right wing sequence of the exogenous gene. According to the corn transformation event provided by the invention,exogenous gene specificity can be introduced into a corn strain, and the receptor is endowed with efficient utilization of corn potassium nutrition and herbicide glufosinate-ammonium resistance. Theexogenous gene can be stably inherited in the receptor corn; expression of the exogenous gene can improve the potassium absorption and utilization efficiency of the receptor corn. According to the detection method, molecular marker detection can be carried out by utilizing a transformation event, and the breeding work efficiency is improved.
Owner:DALIAN UNIV OF TECH

Real-time fluorescent quantitative PCR (Polymerase Chain Reaction) primers for distinguishing clade 7.2 type H5 AIV (H5 Subtype Avian Influenza Virus) from clade 2.3.4.4 type H5 AIV

The invention provides a group of real-time fluorescent quantitative PCR (Polymerase Chain Reaction) primers for distinguishing a clade 7.2 type H5 AIV (H5 Subtype Avian Influenza Virus) from a clade 2.3.4.4 type H5 AIV, and the real-time fluorescent quantitative PCR primers are designed by utilizing GC content difference existing in characteristic nucleotide sequences of HA (Hemagglutin) genes of the clade 7.2 type H5 AIV and the clade 2.3.4.4 type H5 AIV. The clade 7.2 type H5 AIV and the clade 2.3.4.4 type H5 AIV are effectively distinguished by utilizing the phenomena that both the real-time fluorescent quantitative PCR primers can be effectively amplified when real-time fluorescent quantitative PCR is carried out on the clade 7.2 type H5 AIV and the clade 2.3.4.4 type H5 AIV, but the real-time fluorescent quantitative PCR primers have melting temperature (Tm value) difference existing in melting curves generated after the real-time fluorescent quantitative PCR is carried out on the clade 7.2 type H5 AIV and the clade 2.3.4.4 type H5 AIV. By matching with a computer which is connected with a real-time fluorescent quantitative PCR instrument and utilizing analysis software of the real-time fluorescent quantitative PCR instrument, specific identification and diagnosis on infection situations of the clade 7.2 type H5 AIV and the clade 2.3.4.4 type H5 AIV can be achieved by just one group of primers. According to the real-time fluorescent quantitative PCR primers provided by the invention, an identification method is simple, and the efficiency and an accuracy rate are higher.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY FUJIAN ACADEMY OF AGRI SCI

Characteristic sequence, specific identification primer and identification method for identifying crassostrea sikamea

The invention discloses a characteristic sequence, specific identification primer and identification method for identifying crassostrea sikamea. The characteristic sequence is located in a mitochondrial non-coding region between glycine tRNA synthetase and proline tRNA synthetase of the crassostrea sikamea, and the characteristic sequence is a nucleotide sequence as shown in SEQ ID NO.1; a sequence of the specific identification primer comprises an upstream primer MNR-F: 5' -CTGTAAGTATATTTGTCTTCCA-3' ; and a downstream specific primer MNR-S-R: 5' -AGGCTTTCACTCCACTTACT-3' . According to the invention, the crassostrea sikamea can be effectively distinguished from other four drassostrea species, the length of the determined characteristic sequence of the crassostrea sikamea is 660+/-5 bp, and whether the crassostrea sikamea exists or not can be judged according to the existence and the size of a specific band. In the field of crassostrea sikamea germplasm resource protection and crassostrea sikamea breeding, species identification can be conducted on parent crassostrea sikamea before seed breeding, and it is guaranteed that bred seeds are purebreds and are not affected by other species possibly hybridized with the bred seeds.
Owner:浙江万里学院宁海海洋生物种业研究院 +1

Ticket identification device and ticket information management system

The invention provides a ticket identification device and a ticket information management system. The device is used for identifying contents recorded on a plurality of predetermined tickets and managing the identified contents, and is characterized in that the device comprises a template storage part, an OCR control part, a universal OCR identification part, a template matching part and at leastone specific OCR identification part, wherein the template storage part is used for storing ticket template data corresponding to a ticket template of each type of ticket; the ticket template data comprises specific area position information corresponding to a specific area needing to be recognized by a specific OCR recognition part in the ticket; the OCR control part controls the universal OCR identification part to carry out preliminary identification on the ticket image to be identified; the template matching part is used for matching ticket template data corresponding to the ticket to be identified as current ticket template data based on a preliminary identification result; and the OCR control part is used for controlling the specific OCR part to carry out specific identification on characters in the specific area so as to identify corresponding specific contents.
Owner:RICOH IMAGING TECH SHANGHAI CO LTD

Medicament carrier for targeted medicament delivery on diseases related to macrophage and preparation method thereof

This invention discloses a medicament carrier for targeted medicament delivery on diseases related to macrophage and a preparation method thereof, the medicament carrier is hollow virus-like particles formed by prokaryotic expression and self-assembly of rotavirus coat protein Vp6 with specific identification ability to the macrophage; the internal surface or the external surface of the medicament carrier is chemically modified with medicament molecules. The preparation method comprises the following steps: firstly, extracting genes of structural protein Vp6 of A group rotavirus; secondly, cloning the genes of the structural protein Vp6 to a prokaryotic expression carrier; thirdly, performing expression in colibacillus BL21; and finally, crosslinking the expressed protein with the medicament and performing assembly to obtain the virus-like particles. By using the specific identification ability of the virus-like particles to the macrophage, medicaments are delivered to the macrophage to realize the functions of the targeted medicament delivery and slow release. The medicament carrier of the invention can effectively reduce the dosage and toxicity of the medicaments, prevent the medicaments from being degraded by internal environment, improve treating effect, and realize mass production and reduce manufacture cost at the same time.
Owner:SUZHOU INST OF NANO TECH & NANO BIONICS CHINESE ACEDEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products